Haig P. Bozigian
2017
In 2017, Haig P. Bozigian earned a total compensation of $3M as Chief Development Officer at Neurocrine Biosciences, a 9% increase compared to previous year.
Compensation breakdown
| Bonus | $235,060 |
|---|---|
| Option Awards | $1,825,536 |
| Salary | $408,800 |
| Stock Awards | $458,344 |
| Other | $41,694 |
| Total | $2,969,434 |
Bozigian received $1.8M in option awards, accounting for 61% of the total pay in 2017.
Bozigian also received $235.1K in bonus, $408.8K in salary, $458.3K in stock awards and $41.7K in other compensation.
Rankings
In 2017, Haig P. Bozigian's compensation ranked 3,674th out of 14,666 executives tracked by ExecPay. In other words, Bozigian earned more than 74.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,674 out of 14,666 | 75th |
Division Manufacturing | 1,269 out of 5,768 | 78th |
Major group Chemicals And Allied Products | 358 out of 2,074 | 83rd |
Industry group Drugs | 276 out of 1,730 | 84th |
Industry Biological Products, Except Diagnostic Substances | 54 out of 316 | 83rd |
Source: SEC filing on April 9, 2020.
Bozigian's colleagues
We found four more compensation records of executives who worked with Haig P. Bozigian at Neurocrine Biosciences in 2017.